Table 1 The total and differential leucocytic counts in the BALF pellets of the control and all experimental groups.

From: A novel protective role of sacubitril/valsartan in cyclophosphamide induced lung injury in rats: impact of miRNA-150-3p on NF-κB/MAPK signaling trajectories

Groups

Total cells count × 105

Lymphocytes %

Neutrophils %

Macrophages %

Eosinophils %

Control

4.48 ± 0.33

13.25 ± 0.88

2.92 ± 0.37

83.17 ± 6.9

0.55 ± 0.05

ENT

4.46 ± 0.46

11.88 ± 2.02

2.87 ± 0.12

84.63 ± 3.59

0.49 ± 0.09

VAL

4.46 ± 0.49

11.6 ± 1.93

2.9 ± 0.44

84.11 ± 5.61

0.51 ± 0.08

CP

12.8 ± 0.7*

5.47 ± 1.29*

45.3 ± 3.08*

43.2 ± 6.49*

5.15 ± 0.65*

ENT + CP

4.8 ± 0.49#

9.63 ± 0.59*#

10.9 ± 1.12*#

77.9 ± 6.77#

1.22 ± 0.16#

VAL + CP

5.85 ± 0.96#

9.41 ± 0.96*#

13.63 ± 2.32*#

74.5 ± 7.48#

1.84 ± 0.27*#

  1. Data are presented as the mean ± SD (One-way ANOVA followed by Tukey’s multiple comparison test; *P < 0.05, versus the control group; #P < 0.05, versus the CP-treated group).
Back to article page